Skip to content

Physiotherapy as a Complimentary treatment in Reducing Viral-Load, Complications, Death, Expedite Discharge and Improve Quality of Life, Exercise Endurance and Capacity in Stroke Survivors with COVID-19: A Clinical-Controlled Study

Physiotherapy as a Complimentary Treatment in Reducing Odds of Developing Complications, Expedite Hospital Discharge and Death in Stroke Survivors Positive for COVID-19: A Clinical Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202007589336711
Enrollment
30
Registered
2020-07-14
Start date
2020-07-13
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases

Interventions

Electronic Stroke Rehabilitation program in addition to their pharmacological treatment
Usual treatment for patients with CoViD19 apart from physiotherapy

Sponsors

Caleb Ademola Omuwa Gbiri
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Stroke survivors positive for CoViD-19 and age, sex and co-morbid health status-matched CoViD positive individuals 2. The stroke survivors must have been discharge from in-patient stroke care unit

Exclusion criteria

Exclusion criteria: 1. Must not primarily admitted for stroke or stroke complications 2. Must have been discharged from inpatient stroke care and must have been receiving outpatient rehabilitation for at least one month before diagnosis of COVID19

Design outcomes

Primary

MeasureTime frame
1. Cycle Threshold and Number of Nucleic Acid from Quantitative Real Time Polymerase Chain Reaction. ;Exercise tolerance

Secondary

MeasureTime frame
Discharge

Countries

Nigeria

Contacts

Public ContactJibrin Usman

Lecturer College of Health Sciences Bayero University Kano Nigeria

jibrilphysio@yahoo.com+2348099995088

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026